- Home
- GAU vs ITOS Comparison
GAU vs ITOS Comparison
Compare GAU & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAU
- ITOS
- Stock Information
- Founded
- GAU 1999
- ITOS 2011
- Country
- GAU Canada
- ITOS United States
- Employees
- GAU N/A
- ITOS N/A
- Industry
- GAU
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GAU
- ITOS Health Care
- Exchange
- GAU Nasdaq
- ITOS Nasdaq
- Market Cap
- GAU 339.1M
- ITOS 283.9M
- IPO Year
- GAU N/A
- ITOS 2020
- Fundamental
- Price
- GAU $1.23
- ITOS $7.30
- Analyst Decision
- GAU Strong Buy
- ITOS Strong Buy
- Analyst Count
- GAU 2
- ITOS 3
- Target Price
- GAU $3.43
- ITOS $21.33
- AVG Volume (30 Days)
- GAU 524.6K
- ITOS 535.6K
- Earning Date
- GAU 02-13-2025
- ITOS 11-12-2024
- Dividend Yield
- GAU N/A
- ITOS N/A
- EPS Growth
- GAU N/A
- ITOS N/A
- EPS
- GAU N/A
- ITOS N/A
- Revenue
- GAU $166,788,000.00
- ITOS $35,000,000.00
- Revenue This Year
- GAU N/A
- ITOS $271.18
- Revenue Next Year
- GAU $67.18
- ITOS N/A
- P/E Ratio
- GAU N/A
- ITOS N/A
- Revenue Growth
- GAU N/A
- ITOS N/A
- 52 Week Low
- GAU $0.65
- ITOS $7.09
- 52 Week High
- GAU $2.00
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- GAU 36.88
- ITOS 29.34
- Support Level
- GAU $1.19
- ITOS $7.44
- Resistance Level
- GAU $1.34
- ITOS $7.96
- Average True Range (ATR)
- GAU 0.06
- ITOS 0.38
- MACD
- GAU -0.01
- ITOS -0.07
- Stochastic Oscillator
- GAU 14.58
- ITOS 5.41
About GAU Galiano Gold Inc.
Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages the Asanko Gold Mine, located in Ghana, West Africa. Its Asanko Gold Mine is a multi-deposit complex, with two main deposits, the Obotan Project and the Esaase Project, both located in the Amansie West District of the Republic of Ghana, West Africa.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.